Editorial: trends in paediatric inflammatory bowel disease attributable direct costs-authors' reply

被引：0

作者：

El-Matary, Wael ^{[1
,2
]}

Nugent, Zoann ^{[2
,3
]}

Witt, Julia ^{[4
]}

Bernstein, Charles N. ^{[2
,3
]}

机构：

[1] Univ Manitoba, Dept Pediat, Winnipeg, MB, Canada

[2] Univ Manitoba, IBD Clin & Res Ctr, Winnipeg, MB, Canada

[3] Univ Manitoba, Dept Internal Med, Winnipeg, MB, Canada

[4] Univ Manitoba, Dept Econ, Winnipeg, MB, Canada

来源：

ALIMENTARY PHARMACOLOGY & THERAPEUTICS | 2021年 / 53卷 / 11期

关键词：

CROHNS-DISEASE; CHILDREN; TNF;

D O I：

10.1111/apt.16376

中图分类号：

R57 [消化系及腹部疾病];

学科分类号：

摘要：

LINKED CONTENT This article is linked to El-Matary et al and Vernon-Roberts & Day papers. To view these articles, visit and

引用

页码：1234 / 1235

页数：2

共 50 条

[41] Paediatric bowel ultrasound in inflammatory bowel disease
Elliott, Claire L.
Maclachlan, Jody
Beal, Isobel
[J]. EUROPEAN JOURNAL OF RADIOLOGY, 2018, 108 : 21 - 27
[42] Editorial: rising rates of venous thromboembolism among hospitalised patients with inflammatory bowel disease in the USA-authors' reply
Lee, Kate E.
Faye, Adam S.
[J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 56 (07) : 1213 - 1214
[43] Editorial: progress towards more comprehensively understanding the sources of corticosteroids for patients with inflammatory bowel disease-authors' reply
Rosiou, Konstantina
Selinger, Christian P.
[J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 56 (05) : 898 - 899
[44] Editorial: adjuvanted recombinant zoster vaccine in adults with inflammatory bowel disease-time for universal recommendation? Authors' reply
Caldera, Freddy
Spaulding, Aaron C.
Hayney, Mary S.
Farraye, Francis A.
[J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2023, 57 (11) : 1345 - 1346
[45] Editorial: missed opportunities to detect colorectal cancer in inflammatory bowel disease-getting to the root. Authors' reply
Chee, Desmond
Kennedy, Nicholas A.
Goodhand, James R.
Ahmad, Tariq
[J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2021, 53 (02) : 337 - 338
[46] Editorial: which inflammatory bowel disease patients should be screened for Epstein-Barr virus infection? Authors' reply
de Francisco, Ruth
Castano-Garcia, Andres
Riestra, Sabino
[J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2018, 48 (10) : 1159 - 1160
[47] TRENDS IN PEDIATRIC INFLAMMATORY BOWEL DISEASE-ATTRIBUTIBLE DIRECT COSTS: A CANADIAN POPULATION-BASED ANALYSIS
El-Matary, Wael
Nugent, Zoann
Witt, Julia C.
Bernstein, Charles N.
[J]. GASTROENTEROLOGY, 2021, 160 (06) : S88 - S88
[48] Editorial: measuring disease severity in inflammatory bowel disease-the whole is greater than the sum of its parts. Authors' reply
Swaminathan, Akhilesh
Mules, Thomas C.
Gearry, Richard B.
[J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2022, 56 (04) : 746 - 747
[49] Towards optimal thiopurine therapy for inflammatory bowel disease-authors' reply
Vasudevan, Abhinav
Con, Danny
van Langenberg, Daniel R.
[J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2024, 59 (06) : 794 - 794
[50] Letter: causes of fatigue in inflammatory bowel disease remain uncertain - authors' reply
Artom, M.
Czuber-Dochan, W.
Norton, C.
[J]. ALIMENTARY PHARMACOLOGY & THERAPEUTICS, 2017, 45 (05) : 763 - 764

← 1 2 3 4 5 →